Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells.

Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet (2008) 1.96

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med (2011) 1.79

Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis. PLoS One (2009) 1.01

BRCA1 and microRNAs: emerging networks and potential therapeutic targets. Mol Cells (2012) 0.90

A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties. J Biol Chem (2013) 0.86

Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction. Neoplasia (2013) 0.81

The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription (2012) 0.81

Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites. PLoS One (2013) 0.78

Positional analyses of BRCA1-dependent expression in Saccharomyces cerevisiae. Cell Cycle (2008) 0.77

The genomic signature of breast cancer prevention. Genes (Basel) (2014) 0.77

DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev (1998) 6.96

NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell (1999) 6.34

Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics (2003) 3.75

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst (2002) 3.40

Genes associated with breast cancer metastatic to bone. J Clin Oncol (2006) 3.21

Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol Cell Biol (2002) 2.59

BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet (1998) 2.55

BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1997) 2.55

BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54

Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev (2004) 2.35

Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol (2003) 2.21

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol (2005) 2.03

BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol (2001) 1.96

The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression. Cell (2001) 1.95

Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res (1998) 1.93

Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science (1999) 1.67

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci U S A (2001) 1.56

Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res (2006) 1.42

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int J Cancer (1999) 1.40

cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene (2003) 1.34

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24

Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res (2006) 1.09

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol (2005) 1.07

BRCA1 associates with processive RNA polymerase II. J Biol Chem (2003) 1.05

Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bull Cancer (1992) 0.98

Regulation of clustered gene expression by cofactor of BRCA1 (COBRA1) in breast cancer cells. Oncogene (2006) 0.96

Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clin Exp Metastasis (2007) 0.94

Deregulation of cofactor of BRCA1 expression in breast cancer cells. J Cell Biochem (2008) 0.94

BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II. Oncogene (2004) 0.92

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells. APMIS (2003) 0.92

Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol (2003) 0.90

Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression. J Invest Dermatol (2004) 0.82

BRCA1-mediated repression of select X chromosome genes. J Transl Med (2004) 0.81

Characterization of COBRA1 in human breast cancer cell lines using a new polyclonal antibody against COBRA1. IUBMB Life (2004) 0.79

Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science (2005) 6.88

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res (2006) 4.20

Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol (2013) 4.04

Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase. Science (2003) 3.92

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest (2007) 3.89

Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature (2010) 3.72

Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell (2008) 3.26

Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation (2008) 2.98

The structural basis of actin filament branching by the Arp2/3 complex. J Cell Biol (2008) 2.82

The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature (2004) 2.73

Motility and segregation of Hsp104-associated protein aggregates in budding yeast. Cell (2011) 2.72

Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe (2008) 2.68

Endocytosis optimizes the dynamic localization of membrane proteins that regulate cortical polarity. Cell (2007) 2.61

Robust cell polarity is a dynamic state established by coupling transport and GTPase signaling. J Cell Biol (2004) 2.56

Rho1 directs formin-mediated actin ring assembly during budding yeast cytokinesis. Curr Biol (2002) 2.38

Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev (2004) 2.35

The Arp2/3 complex is required for lamellipodia extension and directional fibroblast cell migration. J Cell Biol (2012) 2.34

The Ran GTPase mediates chromatin signaling to control cortical polarity during polar body extrusion in mouse oocytes. Dev Cell (2007) 2.27

ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest (2008) 2.16

Mapping dynamic protein interactions in MAP kinase signaling using live-cell fluorescence fluctuation spectroscopy and imaging. Proc Natl Acad Sci U S A (2007) 2.06

Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol (2003) 1.94

MicroRNA-204/211 alters epithelial physiology. FASEB J (2010) 1.83

Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature (2012) 1.82

Unusual variants of Alexander's disease. Ann Neurol (2005) 1.76

Dual modes of cdc42 recycling fine-tune polarized morphogenesis. Dev Cell (2009) 1.73

Dynamic maintenance of asymmetric meiotic spindle position through Arp2/3-complex-driven cytoplasmic streaming in mouse oocytes. Nat Cell Biol (2011) 1.73

Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine (2011) 1.70

Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell (2011) 1.68

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates. Fertil Steril (2007) 1.65

Actin-driven chromosomal motility leads to symmetry breaking in mammalian meiotic oocytes. Nat Cell Biol (2008) 1.65

microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun (2010) 1.63

Symmetry breaking in the life cycle of the budding yeast. Cold Spring Harb Perspect Biol (2009) 1.62

Cortactin regulates cell migration through activation of N-WASP. J Cell Sci (2004) 1.61

Spontaneous cell polarization: undermining determinism. Nat Cell Biol (2003) 1.59

Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.55

ARPC1/Arc40 mediates the interaction of the actin-related protein 2 and 3 complex with Wiskott-Aldrich syndrome protein family activators. J Biol Chem (2004) 1.53

Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions. PLoS Biol (2005) 1.52

Cell cycle-regulated trafficking of Chs2 controls actomyosin ring stability during cytokinesis. Mol Biol Cell (2005) 1.49

Dynamics of yeast Myosin I: evidence for a possible role in scission of endocytic vesicles. Curr Biol (2004) 1.47

Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol (2008) 1.42

Actin depolymerization drives actomyosin ring contraction during budding yeast cytokinesis. Dev Cell (2012) 1.41

Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta (2011) 1.41

Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet (2003) 1.40

Serum protein profiles in myasthenia gravis. Ann Thorac Surg (2009) 1.39

General regulatory factors (GRFs) as genome partitioners. J Biol Chem (2002) 1.39

Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res (2009) 1.39

Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr Opin Cell Biol (2010) 1.38

A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med (2008) 1.38

Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol (2014) 1.36

Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genet (2012) 1.36

mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol (2007) 1.34

Comparison of ABF1 and RAP1 in chromatin opening and transactivator potentiation in the budding yeast Saccharomyces cerevisiae. Mol Cell Biol (2004) 1.33

Robust classification modeling on microarray data using misclassification penalized posterior. Bioinformatics (2005) 1.32

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J (2010) 1.32

Direct evidence for a critical role of myosin II in budding yeast cytokinesis and the evolvability of new cytokinetic mechanisms in the absence of myosin II. Mol Biol Cell (2003) 1.32

The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab (2008) 1.32

miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res (2012) 1.29

Prediction of drug combination chemosensitivity in human bladder cancer. Mol Cancer Ther (2007) 1.29

Three-dimensional reconstructions of Arp2/3 complex with bound nucleation promoting factors. EMBO J (2011) 1.29

Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol Cell (2012) 1.28

miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res (2013) 1.27

Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem (2011) 1.26

Bni5p, a septin-interacting protein, is required for normal septin function and cytokinesis in Saccharomyces cerevisiae. Mol Cell Biol (2002) 1.25

Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene (2005) 1.25

Ancient orphan crop joins modern era: gene-based SNP discovery and mapping in lentil. BMC Genomics (2013) 1.24

Mitochondrial biogenesis and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes (2010) 1.24

CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med (2012) 1.23

Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial Transplant (2007) 1.20

A missense mutation in the gammaD-crystallin gene CRYGD associated with autosomal dominant congenital cataract in a Chinese family. Mol Vis (2006) 1.19

Complete genome sequence of Bacillus subtilis BSn5, an endophytic bacterium of Amorphophallus konjac with antimicrobial activity for the plant pathogen Erwinia carotovora subsp. carotovora. J Bacteriol (2011) 1.19

Saccharomyces cerevisiae Bzz1p is implicated with type I myosins in actin patch polarization and is able to recruit actin-polymerizing machinery in vitro. Mol Cell Biol (2002) 1.18

Actin cytoskeleton in cell polarity and asymmetric division during mouse oocyte maturation. Cytoskeleton (Hoboken) (2012) 1.18

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler Thromb Vasc Biol (2011) 1.16

NMR analyses of the activation of the Arp2/3 complex by neuronal Wiskott-Aldrich syndrome protein. Biochemistry (2005) 1.16

The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood (2012) 1.15

Actin polymerization: riding the wave. Curr Biol (2004) 1.15

Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF-ET cycles. Reprod Biol Endocrinol (2010) 1.14

The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27. Am J Hum Genet (2006) 1.13

Flippase-mediated phospholipid asymmetry promotes fast Cdc42 recycling in dynamic maintenance of cell polarity. Nat Cell Biol (2012) 1.12

Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Res (2012) 1.12

Genome-wide analysis of ARS (autonomously replicating sequence) binding factor 1 (Abf1p)-mediated transcriptional regulation in Saccharomyces cerevisiae. J Biol Chem (2004) 1.12

Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. Am J Physiol Endocrinol Metab (2006) 1.11

TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2+) influx. Cell Calcium (2010) 1.11

Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin. PLoS One (2008) 1.11

Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs. Mol Ther (2012) 1.10

Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts. Development (2010) 1.10

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals. Cancer Lett (2008) 1.10

Ethnobotanical studies on medicinal plants used by the red-headed yao people in Jinping, Yunnan Province, China. J Ethnopharmacol (2004) 1.09

Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. Cancer Cell (2013) 1.09

Human negative elongation factor activates transcription and regulates alternative transcription initiation. J Biol Chem (2009) 1.09

SAM domain-based protein oligomerization observed by live-cell fluorescence fluctuation spectroscopy. PLoS One (2008) 1.08

Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab (2009) 1.08

Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle. PLoS One (2011) 1.07

Herbs for medicinal baths among the traditional Yao communities of China. J Ethnopharmacol (2006) 1.07

Rapid de-localization of actin leading edge components with BDM treatment. BMC Cell Biol (2003) 1.07

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis (2010) 1.06

JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev (2002) 1.06

Mitotic-exit control as an evolved complex system. Cell (2005) 1.06

Identification of a multifunctional domain in autonomously replicating sequence-binding factor 1 required for transcriptional activation, DNA replication, and gene silencing. Mol Cell Biol (2002) 1.05

LIM kinase 2 is widely expressed in all tissues. J Histochem Cytochem (2006) 1.05